DD202714A5 - Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate - Google Patents

Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate Download PDF

Info

Publication number
DD202714A5
DD202714A5 DD82241446A DD24144682A DD202714A5 DD 202714 A5 DD202714 A5 DD 202714A5 DD 82241446 A DD82241446 A DD 82241446A DD 24144682 A DD24144682 A DD 24144682A DD 202714 A5 DD202714 A5 DD 202714A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
deep
compounds
alkyl
Prior art date
Application number
DD82241446A
Other languages
German (de)
English (en)
Inventor
Peter E Cross
Roger P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202714A5 publication Critical patent/DD202714A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD82241446A 1981-07-07 1982-07-06 Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate DD202714A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8120878 1981-07-07
GB8213864 1982-05-13

Publications (1)

Publication Number Publication Date
DD202714A5 true DD202714A5 (de) 1983-09-28

Family

ID=26280039

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82241446A DD202714A5 (de) 1981-07-07 1982-07-06 Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate

Country Status (17)

Country Link
US (1) US4451472A (pt)
EP (1) EP0069513B1 (pt)
AR (1) AR230056A1 (pt)
AU (1) AU532640B2 (pt)
CS (1) CS229934B2 (pt)
DD (1) DD202714A5 (pt)
DE (1) DE3275545D1 (pt)
DK (1) DK297382A (pt)
ES (1) ES513765A0 (pt)
FI (1) FI822386A7 (pt)
GB (1) GB2101992A (pt)
GR (1) GR76214B (pt)
IL (1) IL66223A0 (pt)
NO (1) NO822360L (pt)
PL (1) PL240814A1 (pt)
PT (1) PT75191B (pt)
YU (1) YU145482A (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
CA2030557A1 (en) * 1989-03-31 1990-10-01 Hiroshi Matsui Imidazole derivatives, methods for their production and pharmaceutical use thereof
JPH03258779A (ja) * 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
EP2736887B1 (en) 2011-07-29 2017-10-18 Karyopharm Therapeutics, Inc. Hydrazide containing nuclear transport modulators and uses thereof
IN2014DN09434A (pt) 2012-05-09 2015-07-17 Karyopharm Therapeutics Inc
WO2014144772A1 (en) 2013-03-15 2014-09-18 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
CN110386919B (zh) 2013-06-21 2023-07-14 卡尔约药物治疗公司 核转运调节剂及其用途
CN111484483B (zh) 2014-08-15 2023-05-26 卡尔约药物治疗公司 赛灵克斯的多晶型物
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3445472A (en) * 1965-12-03 1969-05-20 American Home Prod Mono- and di-aroyl pyridylethyl and piperidylethyl indoles
FR2272081A1 (en) * 1974-05-22 1975-12-19 Labaz Anti-inflammatory indolylpyridylketones prepn. - from 2-alkyl (or aryl) indole and pyridine carboxylic acid chlorides
DE2960547D1 (en) * 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
GB2045244B (en) * 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4363912A (en) * 1980-12-15 1982-12-14 Pfizer Inc. Indole thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
DK297382A (da) 1983-01-08
YU145482A (en) 1985-03-20
FI822386A0 (fi) 1982-07-05
EP0069513A3 (en) 1984-03-21
AR230056A1 (es) 1984-02-29
ES8305355A1 (es) 1983-04-01
PT75191A (en) 1982-08-01
AU8563882A (en) 1983-02-03
AU532640B2 (en) 1983-10-06
FI822386L (fi) 1983-01-08
IL66223A0 (en) 1982-11-30
ES513765A0 (es) 1983-04-01
GB2101992A (en) 1983-01-26
FI822386A7 (fi) 1983-01-08
PT75191B (en) 1985-10-04
DE3275545D1 (en) 1987-04-09
US4451472A (en) 1984-05-29
EP0069513A2 (en) 1983-01-12
EP0069513B1 (en) 1987-03-04
CS229934B2 (en) 1984-07-16
GR76214B (pt) 1984-08-04
PL240814A1 (en) 1983-10-10
NO822360L (no) 1983-01-10

Similar Documents

Publication Publication Date Title
DE3008632C2 (pt)
DD215546A5 (de) Verfahren zur herstellung bicyclischer thromboxansynthetase-inhibitoren
CH644597A5 (de) Imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
CH646154A5 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel.
EP1198453B9 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
DD202290A5 (de) Verfahren zur herstellung von indolderivaten
DD264919A5 (de) Verfahren zur herstellung von 5-hydroxy-3-aminochromanen
US4451472A (en) Inhibition of thromboxane synthetase with 3-(heteroalkyl)-indolyl-acrylic acid derivatives
CH646426A5 (en) Process for the preparation of hydantoin derivatives
EP0007399B1 (de) Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DD149511A5 (de) Verfahren zur herstellung von 9-aminoalkylfluorenen
EP0095640A1 (de) Alkylenverbrückte Guanidinothiazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4230714A (en) Imidazole therapeutic agents
DE69002338T2 (de) Pyrrolidin-Derivate und ihre pharmazeutische Verwendung.
DE69214113T2 (de) Neue Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0033156A2 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2930608C2 (de) Alkylthiophenoxyalkylamine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3326164A1 (de) Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1228041A2 (de) Indolderivate und deren verwendung als 5ht2a liganden
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
EP0194579A2 (de) Neue 3-Pyridylmethylnaphthylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4204686A1 (de) Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
DE2522218B2 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
EP0401798A2 (de) Substituierte Aminoalkylbenzolderivate
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel